FRANK GU is an NSERC Senior Industrial Research Chair Professor in Nanotechnology Engineering in the Department of Chemical Engineering and Applied Chemistry at the University of Toronto. Prior to joining the University of Toronto in July 2018, Dr. Gu was an Associate Professor and Canada Research Chair in Nanotechnology Engineering at the University of Waterloo. Dr. Gu received his Ph.D. from Queen’s University, Canada, where he majored in chemical engineering. Following completion of his graduate program, he pursued postdoctoral research at Massachusetts Institute of Technology and Harvard Medical School.
Dr. Gu has established a frontier research program in Nanotechnology Engineering, with important advances in medical and life science applications. Leading-edge projects have produced new materials and tools for targeted drug delivery, rapid pathogen detection, and passive water treatment. His research has had tangible impacts on his field and industry, including mucoadhesive nanoparticles for the treatment of Dry Eye Disease that has led to the creation of MyX Therapeutics, and photocatalytic water treatment technologies that are the core technology of H2nanO Inc, both are Canadian companies. Dr. Gu has authored and co-authored more than 200 journal and conference publications, as well as 25 U.S. and World patents and applications.